Mark J Niciu Ioline D Henter David A Luckenbaugh Carlos A Zarate Jr Dennis S Charney
10.1146/annurev-pharmtox-011613-135950
Annu Rev Pharmacol Toxicol
2014;54:119-39.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/24392693/
Antidepressive Agents / pharmacology Depression / drug therapy Excitatory Amino Acid Antagonists / pharmacology Ketamine / pharmacology
Antidepressive Agents / pharmacology Depression / drug therapy Excitatory Amino Acid Antagonists / pharmacology Ketamine / pharmacology Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review Glycogen Synthase Kinase 3 / metabolism Humans Peptide Elongation Factor 2 / metabolism Randomized Controlled Trials as Topic TOR Serine-Threonine Kinases / metabolism Antidepressive Agents Excitatory Amino Acid Antagonists Peptide Elongation Factor 2 Ketamine MTOR protein, human TOR Serine-Threonine Kinases Glycogen Synthase Kinase 3
PMC4089991
24392693
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds
2014